GBIO
Generation Bio Co
NASDAQ: GBIO · HEALTHCARE · BIOTECHNOLOGY
$5.34
+0.00% today
Updated 2026-02-09
Market cap
$35.98M
P/E ratio
—
P/S ratio
2.36x
EPS (TTM)
$-9.37
Dividend yield
—
52W range
$3 – $7
Volume
0.1M
Generation Bio Co (GBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-28.12M | $-40.35M | $-70.14M | $-91.82M | $-102.45M | $-52.74M | $-88.56M |
| Capital expenditures | $3.02M | $19.99M | $5.52M | $5.96M | $8.80M | $7.40M | $2.40M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $3.49M | $4.21M | $8.41M | $17.86M | $24.45M | $24.34M | $14.61M |
| Free cash flow | $-31.14M | $-60.33M | $-75.66M | $-97.78M | $-111.25M | $-60.14M | $-90.96M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $47.76M | $315.90M | $-281.97M | — | — |